Evidence map›Paper›PMID 42239243›Full record

ArticlebioRxiv : the preprint server for biology2026

Subcortical recruitment dissociates isoflurane emergence from distinct wakeful states in mice.

C Neiswanger, L K MacMillen, A D Murry, E R Szelenyi, J Navarrete, Mhc Nota, H Lazaro, C C Shin, J Zhang, E A Apley and 11 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

C NeiswangerCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.ORCID 0000-0003-3137-3574
L K MacMillenCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.ORCID 0000-0003-2127-8768
A D MurryCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.
E R SzelenyiDepartment of Neurobiology and Biophysics, University of Washington, Seattle, WA, U.S.A.ORCID 0000-0003-2636-0912
J NavarreteCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.ORCID 0000-0001-9417-4033
Mhc NotaCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.ORCID 0000-0002-6625-5781
H LazaroCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.
C C ShinCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.ORCID 0009-0006-9171-3410
J ZhangCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.
E A ApleyCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.
Y ZhangCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.
C DiazCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.
K N SchneiderCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.
N L GoodwinCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.ORCID 0000-0002-1059-7491
M JinMedical Scientist Training Program, Columbia University Irving Medical Center, New York, NY, U.S.A.
Sro NilssonPlatea Biosciences Inc, Seattle, WA.
K K IshiiCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.ORCID 0000-0002-7956-0806
G D StuberCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.ORCID 0000-0003-1730-4855
M R BruchasCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.ORCID 0000-0003-4713-7816
S A GoldenCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.ORCID 0000-0002-2104-2272
M HeshmatiCenter for Excellence in Neurobiology of Addiction Pain and Emotion, University of Washington, Seattle, WA, U.S.A.ORCID 0000-0003-1549-558X

Funding

University of Washington Center of Excellence in Opioid Addiction ResearchP30DA048736 · NIDA · UNIVERSITY OF WASHINGTON · PI Charles Chavkin · 2019 to 2026
$13.0M
DISSECTING DYNORPHIN-KAPPA OPIOID MEDIATED REINSTATEMENT OF NICOTINE PREFERENCER37DA033396 · NIDA · WASHINGTON UNIVERSITY · PI Michael R. Bruchas · 2018 to 2026
$3.8M
Mechanisms of emergence from general anesthesiaR35GM146751 · NIGMS · UNIVERSITY OF WASHINGTON · PI Mitra Heshmati · 2022 to 2026
$2.3M
Clear Volume Imaging with Machine Learning: a novel tool to identify brain-wide neuronal ensembles of opioid relapse in rat modelsUG3DA053802 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI CHEN, RONG, GOLDEN, SAM · 2021 to 2022
$423k
Cell-type and whole-brain dynamics underlying operant social stress resiliencyF31MH133295 · NIMH · UNIVERSITY OF WASHINGTON · PI NAVARRETE, JOVANA · 2023 to 2025
$146k
Dissociable neural mechanisms of reactive versus appetitive aggressionF31MH125587 · NIMH · UNIVERSITY OF WASHINGTON · PI GOODWIN, NASTACIA · 2021 to 2023
$134k
Pain State Modulation of Emergence from AnesthesiaF32GM163495 · NIGMS · UNIVERSITY OF WASHINGTON · PI Carlie Neiswanger · 2026 to 2026
$79k
NIDA NIH HHS P30 DA048736NIDA NIH HHS R37 DA033396NIDA NIH HHS UG3 DA053802NIGMS NIH HHS F32 GM163495NIGMS NIH HHS R35 GM146751NIMH NIH HHS F31 MH125587NIMH NIH HHS F31 MH133295
6 · The paper itself

Abstract

Emergence from general anesthesia, defined by a recovery of consciousness to the wakeful state, is a clinically consequential state transition that remains a passive process dependent on drug clearance. Despite the critical use of anesthesia, the neural circuitry underlying behavioral recovery remains poorly defined. Here, we map whole-brain neural activity during emergence from isoflurane anesthesia in mice using Fos immunolabeling, tissue clearing, and light-sheet microscopy. This approach enables unbiased quantification of neural activity at cellular resolution across the intact whole brain and supports subsequent network analysis. Rather than resembling wakefulness, emergence exhibits widespread cortical suppression alongside selective activation of discrete subcortical nuclei. This pattern of activity includes both previously implicated arousal-related regions and lesser-studied structures linked to respiratory, autonomic, interoceptive, and cerebellar function. By comparing emergence to two behaviorally distinct wakeful control states, we find that control state selection substantially shapes interpretation of whole-brain activity maps. This establishes dual-state comparisons as a broadly useful strategy for state-dependent circuit mapping. Functional network analysis further elucidates candidate central regions that strongly covary together during emergence, with the most integrated region being the ventral orbital cortex. This approach allows for targeted causal investigation, linking brain-wide circuit discovery with future hypothesis-driven mechanistic interrogation. Together, we find that emergence from isoflurane anesthesia reflects selective subcortical recruitment rather than broad global reactivation toward wakefulness.

Identifiers

PMID42239243
PMCPMC13228565

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.